CMS certification 100006
Orlando Health
52 W Underwood St, Orlando, FL 32806
Orlando Health has a CMS overall rating of 4 out of 5 stars. 75% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 9 and worse on 4. Emergency patients spend a median of 2 h 57 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 10,480 completed surveys, 20% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | FL | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 5,049 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 57 min | 2 h 36 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 170 visits sampled | 5 h 32 min | 3 h 40 min | 4 h 17 min |
| Left before being seen Lower is better · 332,931 patients | 1% | 1% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 296 patients | 61% | 73% | 65% |
How Orlando Health compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Orlando HealthThis hospital | 4/5 | 75% | 2 h 57 min | 9 better 4 worse |
| Adventhealth OrlandoSame city | 3/5 | 75% | 2 h 40 min | 11 better 7 worse |
| Orlando VA Medical CenterSame city | 5/5 | 81% | — | 3 better 1 worse |
| Ucf Lake Nona HospitalSame city | 3/5 | 75% | 2 h 18 min | 1 better |
| Orlando Health-Health Central HospitalSame county · Ocoee | 3/5 | 73% | 2 h 29 min | 3 better 1 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Orlando.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 14,199 cases | Too few cases | 2.6% | 3.9% |
| Heart attack 379 cases | Too few cases | 11.4% | 11.9% |
| Heart failure 990 cases | Too few cases | 8.5% | 11.1% |
| Pneumonia 735 cases | Too few cases | 10.1% | 15.2% |
| Stroke 995 cases | Too few cases | 8.8% | 11.9% |
| COPD 280 cases | Too few cases | 7.3% | 8.6% |
| Heart bypass surgery (CABG) 234 cases | Too few cases | 1.2% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.99 likely 0.81 – 1.17 | 1 |
| After hip or knee replacement 1,887 cases | Too few cases | 3% | 4.1% |
| Deaths after a serious but treatable surgical complication 286 cases | No different | 146.42 per 1,000 likely 113.4 per 1,000 – 179.44 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 17,034 cases | No different | 0.52 per 1,000 likely 0.16 per 1,000 – 0.88 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 23,330 cases | No different | 0.17 per 1,000 likely 0.03 per 1,000 – 0.31 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 23,568 cases | No different | 0.19 per 1,000 likely 0.04 per 1,000 – 0.34 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 7,259 cases | No different | 2.41 per 1,000 likely 1.42 per 1,000 – 3.41 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 4,099 cases | No different | 0.98 per 1,000 likely 0 per 1,000 – 2.14 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 3,998 cases | No different | 7.47 per 1,000 likely 3.97 per 1,000 – 10.97 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 7,572 cases | No different | 4.45 per 1,000 likely 3.21 per 1,000 – 5.7 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 4,045 cases | No different | 7.18 per 1,000 likely 5.02 per 1,000 – 9.35 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 1,032 cases | No different | 1.76 per 1,000 likely 0.46 per 1,000 – 3.05 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 4,146 cases | No different | 1.38 per 1,000 likely 0.66 per 1,000 – 2.11 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.38 likely 0.23 – 0.58 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.34 likely 0.18 – 0.58 | 1 |
| Surgical site infections after colon surgery | No different | 1.05 likely 0.7 – 1.5 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.6 likely 0.15 – 1.63 | 1 |
| MRSA bloodstream infections | No different | 1.24 likely 0.9 – 1.67 | 1 |
| C. diff intestinal infections | Better | 0.21 likely 0.15 – 0.29 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 1,030 cases | Too few cases | 14.3% | 14.4% |
| Readmitted after heart failure 2,627 cases | Too few cases | 23.2% | 21.3% |
| Readmitted after pneumonia 1,563 cases | Too few cases | 18.3% | 17.3% |
| Readmitted after COPD 741 cases | Too few cases | 21.7% | 20% |
| Readmitted after heart bypass surgery 336 cases | Too few cases | 12.1% | 11% |
| Readmitted after hip or knee replacement 1,927 cases | Too few cases | 5.6% | 5.8% |
| Days back in hospital after a heart attack 436 cases | Too few cases | -20.3 days per 100 | — |
| Days back in hospital after heart failure 1,221 cases | Too few cases | -1.5 days per 100 | — |
| Days back in hospital after pneumonia 837 cases | Too few cases | -20.1 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 858 cases | No different | 12.3 per 1,000 likely 9.4 per 1,000 – 15.9 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 862 cases | Worse | 15.9 per 100 likely 13.7 per 100 – 18.4 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 862 cases | Better | 3.9 per 100 likely 3 per 100 – 5.1 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,366 cases | No different | 0.9 likely 0.7 – 1.1 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
395 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 115 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Diagnostic Radiology | 80 |
| Internal Medicine | 64 |
| Anesthesiologist Assistant | 40 |
| Adult Health | 32 |
| Nurse Anesthetist, Certified Registered | 28 |
| Anesthesiology | 21 |
| Emergency Medicine | 21 |
| Critical Care Medicine | 14 |
| Family | 14 |
| Registered Nurse | 11 |
| Vascular & Interventional Radiology | 8 |
| Family Medicine | 7 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.6M
- 2020 $4M
- 2021 $3.4M
- 2022 $4M
- 2023 $4.4M
- 2024 $6.6M
- 2025 $6.9M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $748,607 | 34 |
| Space rental and facility fees | $494,591 | 47 |
| Speaking, teaching and other services | $96,163 | 15 |
| Medical devices and supplies on long-term loan | $63,400 | 5 |
| Education | $25,717 | 4 |
| Debt forgiveness | $20,953 | 4 |
| Food and beverage | $1,749 | 40 |
| Gifts | $29 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $787,864 | 448 |
| ModernaTX, Inc. | $622,944 | 83 |
| Boston Scientific Corporation | $479,419 | 20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $441,264 | 48 |
| Medtronic, Inc. | $370,680 | 26 |
| Genzyme Corporation | $315,790 | 24 |
| Ethicon Inc. | $300,390 | 5 |
| Janssen Research & Development, LLC | $292,619 | 66 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| DAREON-8: A Phase I, open-label, dose escalation and expansion trial of repeated intravenous infusions of BI 764532 combined with Standard of care (p… Boehringer Ingelheim Pharmaceuticals, Inc. | $382,790 |
| A PHASE 3 TRIAL OF FIANLIMAB (ANTI-LAG-3) AND CEMIPLIMAB VERSUS PEMBROLIZUMAB IN THE ADJUVANT SETTING IN PATIENTS WITH COMPLETELY RESECTED HIGH-RISK … Regeneron Pharmaceuticals, Inc. · NCT05608291 | $370,164 |
| A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants… ModernaTX, Inc. | $336,709 |
| Safety and Performance of the OTTAVA Robotic System: A Prospective, Multi-Center Evaluation Ethicon Inc. | $300,390 |
| A PHASE 3 TRIAL OF FIANLIMAB (REGN3767, ANTI-LAG-3) + CEMIPLIMAB VERSUS PEMBROLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED UNRESECTABLE LOCALLY ADVA… Regeneron Pharmaceuticals, Inc. · NCT05352672 | $281,036 |
| Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomid… GENZYME CORPORATION · NCT06141473 | $278,350 |
| Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors ModernaTX, Inc. · NCT05533697 | $220,415 |
| A Prospective, Open-Label, Randomized, Phase 3 Trial of Acasunlimab (GEN1046) in Combination With Pembrolizumab Versus Docetaxel in Subjects With PD-… Genmab A/S | $207,687 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Orlando Health
Is Orlando Health a good hospital?
Orlando Health has a CMS overall rating of 4 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 9 and worse on 4. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Orlando Health?
75% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 10,480 completed HCAHPS surveys.
How long is the wait in the Orlando Health emergency room?
Emergency patients spend a median of 2 h 57 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Orlando Health receive money from drug and device companies?
Drug and device makers reported $6.9M in payments to Orlando Health for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.